The Institute for
International Research (IIR) will be holding its 10th Annual Generic Drugs
Summit entitled "Business of Biosimilars: Innovative Tools and Strategies
to Compete in the Evolving Biosimilars Market" on September 23-25, 2009 in
Boston, MA.  The Business of
Biosimilars conference will offer presentations on the following topics:

• Update on proposed biosimilars legislation;
• Evaluating the new business model for
biosimilars;
• Wall Street address:  How investors evaluate the new competitive
dynamics for biosimilars;
• Exclusivity periods and their impact
on competition;
• Analytical techniques for
characterizing — biosimilars vs. biogenerics;
• Assessing the competitive landscape
for biogenerics;
• The payor's perspective on biogenerics;
• The effect of biosmilars on
innovation and innovator pipelines;
• Evaluating the IP implications of
launching a biosimilar (panel discussion);
• Regulatory insights and updates for biosimilars;
• Skill sets, capabilities and
facilities needed for success in biosimilars & biogenerics;
• The science of biosimilars;
• Insights into the European
biosimilars marketplace;
• Commercial and public sector
insurance payment issues, future trends & perspectives; and
• Main Street perspective:  What patients and consumers want from
biosimilars and biogenerics.

An additional
symposium entitled "Technical & Scientific Strategies for Developing
Biosimilars" will be offered from 9:00 am to noon on September 23,
2009.  The symposium will offer
presentations on the following topics:
• Therapeutic
equivalence of proteins and peptides:  Viewpoint from industry innovators;
• Case study:  Overview of delivery technologies for
GLP-1 analogues; and
• Biosimilar development:  Clinical & manufacturing
opportunities & challenges.

An additional
interactive workshop entitled "Prepare to Meet the Requirements —
Understanding Current Legislation & Regulatory Developments for
Biosimilars" will be held from 1:00 pm to 4:00 pm on September 23, 2009.

The agenda for the Business
of Biosimilars conference can be found here.  A complete brochure for this
conference, including an agenda, list of speakers, and registration form can be
requested here.

The registration
fee for the conference is $2,495 (conference alone), $2,795 (conference and one
half-day workshop), or $2,995 (conference and two half-day workshops) for law
firms and consultants.  Attendees
from pharmaceutical, biotech, or generic drug manufacturers can receive a $300
discount off the above fees.  Those
interested in registering for the conference can do so here,
by calling 1-888-670-8200 (or internationally at 941-951-7885, or by email at
register@iirusa.com.